Mesothelioma trials in Japan

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  Where

  Akashi, Fukushima, Hidaka, Koto, Nagaizumi-chō, Ōta, Sapporo, Shinjuku-ku, Yamagata

  Age

  18 years and over

  People

  952 worldwide

  Run by

  Genmab

  See details and how to joinNCT05579366
• Phase 2Taking people
  Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

  Where

  Kashiwa, Yokohama

  Age

  18 years to 64 years

  People

  257 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06535607 · EU 2025-523947-36-00
• Phase 1/2Enrolling by invitation
  Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA

  Where

  Osaka

  Age

  18 years to 85 years

  People

  30

  Run by

  Stella Pharma Corporation

  See details and how to joinNCT06603987